Meike Vogler Selected Research

Meike Vogler Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 11/2005
7	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 04/2009
5	Rhabdomyosarcoma 10/2020 - 01/2018
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 04/2018
3	Leukemia 01/2021 - 02/2009
3	B-Cell Lymphoma (Lymphoma, B Cell) 04/2018 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2009 - 11/2005
2	Multiple Myeloma 01/2020 - 09/2010
2	Neuroblastoma 01/2020 - 11/2005
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 08/2010
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2018
1	Lymphoma (Lymphomas) 01/2017
1	Thrombocytopenia (Thrombopenia) 06/2011
1	Disease Progression 04/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2009
1	Glioblastoma (Glioblastoma Multiforme) 11/2005
1	Residual Neoplasm 11/2005

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
7	venetoclaxIBA 01/2021 - 01/2017
5	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
5	navitoclaxIBA 01/2019 - 04/2009
4	ABT-737IBA 06/2011 - 04/2009
3	Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA 01/2017 - 05/2011
3	CaspasesIBA 09/2010 - 11/2005
2	S63845IBA 10/2020 - 01/2020
2	Inhibitor of Apoptosis ProteinsIBA 01/2020 - 11/2005
2	Proteasome InhibitorsIBA 01/2020 - 09/2010
2	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 01/2018
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 04/2018 - 01/2017
2	Apoptosis Regulatory ProteinsIBA 04/2018 - 03/2013
2	Caspase 3 (Caspase-3)IBA 09/2010 - 03/2009
2	LigandsIBA 03/2009 - 10/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 10/2008
1	guadecitabineIBA 01/2020
1	BDA-366IBA 01/2020
1	tirabrutinibIBA 04/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2018
1	S55746IBA 04/2018
1	AlpelisibIBA 01/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	binimetinibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 03/2013
1	Immunotoxins (Immunotoxin)IBA 03/2013
1	Small Interfering RNA (siRNA)IBA 09/2010
1	RoscovitineIBA 09/2010
1	Bortezomib (Velcade)FDA Link 09/2010
1	AnnexinsIBA 09/2010
1	Propidium (Propidium Iodide)IBA 09/2010
1	AlbuminsIBA 08/2010
1	Cytochromes c (Cytochrome c)IBA 10/2008

Therapy/Procedure

9	Therapeutics 01/2022 - 11/2005
2	Immunotherapy 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2019 - 04/2009
1	Precision Medicine 12/2020